Phase II Trial of Gliadel® plus O(6)-Benzylguanine (O(6)-BG) in Adults with Recurrent Glioblastoma Multiforme

PURPOSE: This phase II trial was designed to: define the efficacy of Gliadel® wafers in combination with an infusion of O(6)-BG that suppresses tumor O(6)-alkylguanine-DNA alkyltransferase (AGT) levels in patients with recurrent GBM for 5 days; and evaluate the safety of this combination therapy. PA...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Quinn, Jennifer A., Jiang, Sara Xiaoyin, Carter, James, Reardon, David A., Desjardins, Annick, Vredenburgh, James J., Rich, Jeremy N., Gururangan, Sridharan, Friedman, Allan H., Bigner, Darell D., Sampson, John H., McLendon, Roger E., Herndon, James E., Threatt, Stevie, Friedman, Henry S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2710963/
https://ncbi.nlm.nih.gov/pubmed/19188181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-2130
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky